Le Lézard

News by subject: TRI

17 december 2023

20:49
GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, formerly referred to as "GC5107," for the treatment of adult patients aged 17 years...

18:35
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium (Consortium). The Consortium...

10:15
YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company's first in vivo genome editing candidate being developed as a single dose, potentially curative therapy for hereditary transthyretin amyloidosis...


16 december 2023

17:00
Thinking about fatherhood? As you embark on this exciting journey, your health matters more than ever. You've probably searched for answers to questions like "how to get pregnant" and "how to prepare." Well, here's a crucial piece of the puzzle:...

02:47
Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over $100M by issuing 8 million new shares. The new funding will enable Caliway to advance the clinical development of its lead pipeline...


15 december 2023

17:00
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced that on December 15, 2023 the U.S. Food and Drug Administration (FDA) has approved PADCEV®...

16:19
Flourish Research announces the acquisition of Merritt Island Medical Research (MIMR) in Merritt Island, Florida. MIMR is a leading clinical research site that specializes in neuroscience related indications...

10:26
Numinus Wellness Inc. ("Numinus" or the "Company") , a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is proud to announce that its...

10:01
According to a recent report by Kings Research, the global Clinical Trial Services Market valuation was recorded at USD 45.12 billion in 2022 and is expected to reach USD 72.54 billion by 2030, growing at a 6.11% CAGR between 2023 and 2030. The...

10:00
Nestlé Health Science today announced the publication of positive clinical trial results in the journal Diabetes, Obesity, and Metabolism showing that the Optifast® meal replacement program led to significantly greater reductions in weight, blood...

09:28
Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced that the company will present at the 13th World Gastroenterology, IBD & Hepatology...

08:37
Long-term use of analgesics such as morphine leads to "tolerance" that reduces drug efficacy. In such cases, dose escalation may be required to achieve the same analgesic effects. The key molecular mechanism of morphine tolerance is its inefficiency...

08:33
Atopic dermatitis (or AD) is a heterogenous, inflammatory condition of the skin and is usually accompanied by itch, redness, and swelling. AD can have a significant impact on the patient's quality of life. While several biologic treatment approaches...

08:10
A study published in this month's issue of the National Kidney Foundation American Journal of Kidney Diseases (AJKD) provides new insights into the role of diet in the management of chronic kidney disease (CKD). "Adherence to Plant-based Diets and...

08:00
Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) and treatment-naïve acute...


14 december 2023

22:14
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that Prof. Xiaoyuan Gong of the Institute of Hematology and Blood...

16:05
Aadi Bioscience, Inc. , a...

15:40
Hansa Biopharma, "Hansa" , today announced full results from the 16-HMedIdeS-12 phase 2 trial in patients with antibody mediated rejection (AMR) episodes following a kidney transplant demonstrating that imlifidase significantly reduced donor-specific...

09:37
An Interim analysis of 18 patients, completing 24/25 weeks of treatment in a phase 2 study in complement-naïve PNH patients demonstrates that KP104 is safe, well-tolerated, and has successfully met all primary and secondary endpoints.KP104...

09:24
A statistically significant, 37.4% difference (P=0.03), slowing of disease progression in ALSFRS-R, in patients treated with PrimeC compared to placebo, in the pre-specified Per Protocol (PP) population analysisNeurofilament biomarker results from...

09:00
CytoImmune Therapeutics announces today a significant extension of its ongoing Phase 1 clinical trial evaluating CYTO-102, now encompassing an additional study site at the Chan Soon-Shiong Institute for Medicine (CSSIFM) in El Segundo, CA. In a...

08:53
Haystack Oncology, a Quest Diagnostics company, has entered into a collaboration with Rutgers Cancer Institute of New Jersey to use Haystack Oncology's industry-leading personalized MRD technology (Haystack MRDtm) to help evaluate therapeutic...

08:36
Celebrating its 25th year as an unparalleled leader in opioid detoxification, the Waismann Method proudly upholds its legacy of innovation and excellence in treating opioid dependence. This landmark anniversary not only highlights a quarter-century...

08:30
Pixie Dust Technologies, Inc. (the "Company"), a Japanese technology company focused on commercializing innovative products and materials utilizing proprietary wave control technology, today announced that a Company-sponsored experiment on the...

03:30
Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today announces that the US Food and Drug...


13 december 2023

23:00
The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately 1.3 billion yen (US$8.8 million1) for the development of new drugs for malaria and Chagas disease.2 Malaria is an infectious parasitic disease...

16:26
10x Genomics, Inc. , a leader in single cell and spatial biology, announced today that a new non-peer-reviewed study has independently evaluated the technical performance of three spatial imaging platforms and found the Xenium In Situ platform...

16:00
Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Company's Biologics License Application (BLA) for tarlatamab. Tarlatamab is a potential...

15:43
Inhibitor Therapeutics, Inc. ("Inhibitor") has entered into an exclusive, worldwide licensing agreement (the "License") with Johns Hopkins University (JHU) for their U.S Patent 8,980,930 (Canada Patent 2,572,223) "New Angiogenesis Inhibitors"....

14:26
Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced today that its groundbreaking clinical study, recently accepted for publication in the Journal of Clinical and Aesthetic Dermatology (JCAD), has further shed light on the...

10:45
UroMems, a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), announced today it has reached a significant milestone: the complete treatment cohort in the first-of-its-kind clinical feasibility...

09:45
The Psoriasis Treatment Center of New Jersey, part of Schweiger Dermatology Group, announced positive results from an open-label clinical trial of VTAMA® (tapinarof) cream, 1% added to injectable biologics to achieve National Psoriasis Foundation...

09:22
A new publication in the journal Plastic and Reconstructive Surgery Global Open shows Lipedema Reduction Surgery outcomes are equal to or better than Total Knee Replacement in improving knee mechanics, gait, physical function, and pain....

09:00
Inovedis GmbH, a medical technology start-up dedicated to offering innovative solutions that contribute both to optimized patient care as well as minimizing the complexity of surgical interventions, today announced that the first two patients were...

08:30
AOC 1044 delivered up to 50-times greater concentrations of PMO in skeletal muscle following a single dose compared to peptide conjugated PMOs in healthy volunteers AOC 1044 was well tolerated, demonstrated statistically significant exon 44 skipping...

08:06
An international team started the research project CERTAINTY in December 2023. Together with partners from science, industry and the healthcare sector, the project team led by the Fraunhofer Institute for Cell Therapy and Immunology IZI aims to...

08:00
Independent study published in Annals of Surgical Oncology concludes cryoablation is an oncologically safe and feasible minimally invasive procedure option in lieu of surgery for patients with early-stage, low-risk breast cancerStudy's authors...

08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced phase II proof-of-concept study...

08:00
Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the dosing of the first patient in Phase 2a clinical trial evaluating its lead...

06:00
Imagion Biosystems Limited recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility of MagSense® HER2 Imaging Agent (MSH2IA) as an adjunct to MRI for the...

05:12
Medivir AB , a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that it has signed an agreement with Lonza for the manufacture of a new GMP campaign of fostrox drug...

05:00
Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering first-in-class novel therapies for atrial fibrillation ("AF"), the most...

05:00
Dizal today announced that the results of a phase 2 pivotal study of sunvozertinib for the treatment of platinum-pretreated non-small-cell lung cancer (NSCLC) patients with EGFR exon 20 insertion mutations (exon20ins) (WU-KONG6) were published in the...

04:52
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the...

03:47
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a randomized, controlled,...

03:30
Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for use in...


12 december 2023

18:40
Clover Biopharmaceuticals, Ltd.?(Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today announced that enrollment of the...

16:05
BIOLASE, Inc. , the global leader in dental lasers, today announced the successful completion of a trial program featuring the Waterlase iPlus All Tissue laser conducted by six leading U.S. dentists. The trial, led by an...

12:09
Johnson & Johnson announced today the first data from the Phase 3 PERSEUS study highlighting significant clinical...

12:00
Patients with relapsed or refractory mantle cell lymphoma (MCL) who received ibrutinib in combination with venetoclax experienced significantly better...